Total investments received (USD): 13.2m
Round value (USD): N/A
Round investors:
Rosetta Capital
Company: Asarina Pharma
Industry:
Health services
Pharma



Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
France
Ireland
Italy
Portugal
Spain